June 8, 2026
June 8, 2026
GSK taps Engitix’s platform in liver fibrosis deal worth up to £44.5m upfront
Share this post
Learn how we are unlocking unprecedented therapies for chronic diseases
Engitix London
4th Floor, The WestWorks,
195 Wood Lane, London, W12 7FQ,
United Kingdom
Registered Office
C/O Mercer & Hole Llp, 3 Lombard Street, London, United Kingdom, EC3V 9AA
